The mechanisms of gastric mucosal injury: Focus on microvascular endothelium as a key target

Current Medicinal Chemistry

Volumn 19, Issue 1, 2012, Pages 4-15

  Tarnawski, A S ^a   Ahluwalia, A ^a   Jones, M K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Endothelium; Gastric mucosa; Injury; Microvessels; Survivin

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANGIOPOIETIN 1; ARACHIDONIC ACID; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BETA2 INTEGRIN; CADHERIN; COLLAGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIN; GHRELIN; GROWTH FACTOR; INTERLEUKIN 1BETA; LEUKOTRIENE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMINOGEN ACTIVATOR; PROSTAGLANDIN; PROTEIN KINASE B; SURVIVIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL PROTECTION; CYTOKINE RELEASE; ERYTHROCYTE; EXTRACELLULAR MATRIX; HUMAN; HYPOXIA; ISCHEMIA; ISCHEMIC PRECONDITIONING; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PORTAL HYPERTENSION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH DISEASE; STOMACH MUCOSA; STOMACH MUCOSA BLOOD FLOW; STOMACH MUCOSA INJURY; THROMBOCYTE AGGREGATION;

EID: 84857538170     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803414079     Document Type: Article

References (122)

1. Tarnawski, A. Cellular and molecular mechanisms of mucosal defense and repair. In:Bioregulation and Its Disorders in Gastrointestinal Tract ., T. Yoshikawa, T. Arakawa, Ed. Blackwell Science, Japan, Tokyo, 1998, pp. 3-17.
2. Laine, L.; Takeuchi, K.; Tarnawski, A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology, 2008, 135, 41-60. (Pubitemid 351899027)
3. deFoneska, A. ; Kaunitz, J.D. Gastroduodenal mucosal defense. Curr Opin Gastroenterol. 2010, 26, 604-610.
4. Hunter, J. Digestion of the stomach after death. Philos Trans R Soc Lond, 1772, 62, 447-454.
5. Virchow, R. Historisches, kritisches und positives zur lehre der unterleibsaffektionen. Arch Pathol Anat., 1853, 5, 281-375.
6. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat N Biol, 1971, 232, 232-235.
7. Robert, A.; Nezamis, J.E.; Lancaster, C.; Hanchar, A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology, 1978, 77, 433-443. (Pubitemid 10132046)
8. Robert, A.; Nezamis, J.E.; Lancaster, C.; Davis, J.P.; Field, S.O.; Hanchar, A.J. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol, 1983, 245, G113-G121. (Pubitemid 14230295)
9. Tarnawski, A. Cytoprotection. A new fashion or real progress? Pol. Arch. Med. Wewn, 1980, 65:97 104.
10. Tarnawski, A.; Hollander, D. Cytoprotection of gastric and duodenal mucosa. The Royal Society of Medicine. Current Medical Literature Gastroenterology, 1987, 6, 3-9.
11. Holzer, P. Sensory nerves and neuropeptides in gastroenterology. From basic science to clinical perspectives. Adv Exp Med Biol 1991, 298, 3-17.
12. Peskar, B.M., Plate, S., Stroff, T. Gastroprotective effects of gut peptides: Role of afferent neurons, calcitonin gene-related peptide and nitric oxide. In: Gastroduodenal Mucosal Damage: Problems of Protection and Healing. Cheli, R.; Iaquinto, G.; Szabo, S., Eds. Medserve, Milano, 1997, pp. 70-83
13. Konturek, S.J.; Brzozowski, T.; Konturek, P.C.; Schubert, M.L.; Pawlik, W.W.; Padol, S.; Bayner, J. Brain-gut and appetite regulating hormones in the control of gastric secretion and mucosal protection. J Physiol Pharmacol., 2008, 59 Suppl 2, 7-31.
14. Takeuchi, K.; Johnson, L.R. Pentagastrin protects against stress ulcerations in rats. Gastroenterology, 1979, 76, 327-334 (Pubitemid 9119035)
15. Konturek, S.J.; Brzozowski, T.; Pytko-Polonczyk, J.; Drozdowicz, D. Exogenous and endogenous cholecystokinin protects gastric mucosa against the damage caused by ethanol in rats. Eur J Pharmacol, 1995, 273, 57-62,.
16. Komori, M.; Tsuji, S.; Sun, W.H.; Tsujii, M.; Kawai, N.; Yasumaru, M.; Kakiuchi, Y.; Kimura, A.; Sasaki, Y.; Higashiyama, S.; Kawano, S.; Hori, M. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats. Am J Physiol Gastrointest Liver Physiol., 2002, 283, G1368-78. (Pubitemid 35351125)
17. Brzozowska, I.; Ptak-Belowska, A.; Pawlik, M.; Pajdo, R.; Drozdowicz, D.; Konturek, S.J.; Pawlik, W.W.; Brzozowski, T. Mucosal strengthening activity of central and peripheral melatonin in the mechanism of gastric defense. J Physiol Pharmacol., 2009, 60 Suppl 7, 47-56.
18. Szlachcic, A.; Brzozowski, T.; Majka, J.; Pajdo, R.; Konturek, P.C.; Pawlik, M.; Kwiecien, S.; Drozdowicz, D.; Bielanski, W.; Konturek, S.J.; Pawlik, W.W. Involvement of Orexigenic Peptides in the Mechanism of Gastric Mucosal Integrity and Healing of Chronic Gastric Ulcers. Curr Pharm Des., 2010, 16, 1214-1223.
19. Guth, P.H. Current concepts in gastric microcirculatory pathophysiology, Yale J Biol Med, 1992, 65, 677-688. (Pubitemid 23277830)
20. Holzer, P. Neural regulation of gastrointestinal blood flow. In: L.R. Johnson, Ed., Physiology of the gastrointestinal tract (4th ed), Academic Press, New York, 2006, pp. 817-839.
21. Fiorucci, S.; Distrutti, E.; Cirino, G.; Wallace, J.L. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver, Gastroenterology, 2006, 131, 259-271. (Pubitemid 44043128)
22. Szabo, S.; Trier, J. Pathogenesis of acute gastric mucosal injury: sulfhydryls as a protector, adrenal cortex as a modulator, and vascular endothelium as a target. In: A. Allen, Ed., Mechanisms of mucosal protection in the upper gastrointestinal tract, Raven Press, New York 1984, pp. 287-293.
23. Szabo, S. Peptides, sulfhydryls, and glucocorticoids in gastric mucosal defense: coincidence or connection? Gastroenterology. 1984, 87, 228-229. (Pubitemid 14122775)
24. Stengel, A.; Goebel-Stengel, M.; Wang, L.; Larauche, M.; Rivier, J.; Taché, Y. Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice. Neurogastroenterol Motil., 2011, 23, e223-236.
25. Taché, Y.; Stengel, A. Interaction between Gastric and Upper Small Intestinal Hormones in the Regulation of Hunger and Satiety: Ghrelin and Cholecystokinin Take the Central Stage. Curr Protein Pept Sci. 2011, 12, 293-304.
26. Guth, P.H.; Leung, F.W. Physiology of the gastric circulation. In: Johnsosn LR, Ed.; Physiology of the gastrointestinal tract. Raven New York, 1987, pp. 1031-1054.
27. Cotran R.S.; Kumar V.; Robbins S.L.: Gastric ulceration. In:Robbins Pathologic Basis of Disease . 5th Edition. (ed.) R.S. Cotran, V. Kumar, S.L. Robbins. Philadelphia, Saunders, 1999, pp 298-299, 773-777.
28. Crissinger, K.D.; Granger, N. Gastrointestinal blood flow. In:Textbook of Gastroenterology 2nd ed. Yamada T., Ed. JB Lippincott Co., Philadelphia, 1995, pp. 518-545.
29. Kawano, S.; Tsuji, S. Role of mucosal blood flow: a cenceptional review in gastric mucosal injury and protection. J Gastroenterol Hepatol, 2000, 15, D1-6 (Pubitemid 30190718)
30. Gannon, B.; Browning, J.; O'Brien, P.; Rogers, P. Mucosal microvascular architecture of the fundus and body of the human stomach. Gastroenterology, 1984, 86, 866-875. (Pubitemid 14132469)
31. Ichikawa, Y.; Tarnawski, A.; Sarfeh, I.J.; Ishikawa, T.; Shimada, H. Distorted microangio-architecture and impaired angiogenesis in gastric mucosa of portal hypertensive rat. Gastroenterology, 1994, 106, 706-708.
32. Yoshida, M.; Wakabayashi, G.; Ishikawa, H.; Kawachi S.; Tanabe, M.; Otani, Y.; Shimazu, M.; Kubota, T.; Kitajima, M. Arteriovenous shunting blood flow is intravitally observed in the stomach after thermal injury in rats. Keio J Med. 2002, 51, 193-200. (Pubitemid 36083280)
33. Sumpio, B.E.; Riley, J.T.; Dardik, A. Cells in focus: endothelial cell. Int J Biochem Cell Biol. 2002, 34, 1508-12
34. Pries, A.R; Kuebler, W.M. Normal endothelium. Handb Exp Pharmacol. 2006, 176 Pt 1, 1-40.
35. Michiels, C. Endothelial cell functions. J Cell Physiol. 2003, 196, 430-43. (Pubitemid 36927738)
36. Yuan, S.Y.; Rigor, R.R. Regulation of Endothelial Barrier Function. In: integrated systems physiology: from molecule to function to disease #12, D.N. Granger and .J P. Granger Eds., San Rafael (CA): Morgan & Claypool Life Sciences, 2010.
37. Lucas, R.; Verin, A.D.; Black, S.M.; Catravas, J.D. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol., 2009, 77, 1763-72.
38. Martin, T.A.; Jiang W.G. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta., 2009, 1788, 872-91.
39. Deanfield, J.; Donald, A.; Ferri, C.; Giannattasio, C.; Halcox, J.; Halligan, S.; Lerman, A.; Mancia, G.; Oliver, J.J.; Pessina, A.C.; Rizzoni, D.; Rossi, G.P.; Salvetti, A.; Schiffrin, E.L.; Taddei, S.; Webb, D.J.Endothelial function and dysfunction. A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens., 2005, 23, 7-17.
40. Wagner, D.D.; Olmsted, J.B.; Marder, V.J. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J. Cell Biol., 1982, 95, 355-360. (Pubitemid 13208536)
41. Bonfanti, R.; Furie, B.C.; Furie, B.; Wagner, D.D. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood, 1989, 73, 1109-1112. (Pubitemid 19107409)
42. McEver, R.P.; Beckstead, J.H.; Moore, K.L.; Marshall-Carlson, L.; Bainton, D.F. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J. Clin. Invest., 1989, 84, 92-99. (Pubitemid 19170099)
43. Kliche, K.; Jeggle, P.; Pavenstädt, H.; Oberleithner, H. Role of cellular mechanics in the function and life span of vascular endothelium. Pflugers Arch., 2011, Feb 12. Epub ahead of print PubMed PMID: 21318292.
44. Gryglewski, R.J. Pharmacology of vascular endothelium. FEBS J., 2005, 272, 2956-67
45. Gryglewski, R.J. Prostacyclin among prostanoids. Pharmacol Rep., 2008, 60, 3-11. (Pubitemid 351586537)
46. Nachman, R.L; Jaffe, E.A. Endothelial cell culture: beginning of modern vascular biology. J Clin Invest 2004, 114, 1037-1040. (Pubitemid 39578688)
47. Vlodavsky, I.; Fridman, R.; Sullivan, R.; Sasse, J.; Klagsbrun, M. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. Cell Physiol., 1987, 131, 402-408. (Pubitemid 17113055)
48. Hannan, R.L.; Kourembanas, S.; Flanders, K.C.; Rogelj, S.J.; Roberts, A.B.; Faller, D.V.; Klagsbrun, M. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors, 1988, 1, 7-17. (Pubitemid 19144091)
49. Bai H; Forrester JV; Zhao M. DC electric stimulation upregulates angiogenic factors in endothelial cells through activation of VEGF receptors. Cytokine, 2011, 55, 110-115.
50. Brandes, R.P.; Schmitz-Winnenthal, F.H.; Félétou ,M.; Gödecke, A.; Huang, P.L.; Vanhoutte, P.M.; Fleming, I.; Busse, R.An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 9747-9752. (Pubitemid 30650847)
51. Fitzgerald, S.M.; Bashari, H.; Cox, J.A.; Parkington, H.C.; Evans, R.G. Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo. Am. J. Physiol. Heart Circ. Physiol., 2007, 293, H1072-H1082. (Pubitemid 47254207)
52. Wu, S.; Wu, X.; Zhu, W.; Cai, W.J.; Schaper, J.; Schaper, W. Immunohistochemical study of the growth factors; aFGF; bFGF; PDGF-AB; VEGF-A and its receptor (Flk-1) during arteriogenesis. Mol Cell Biochem. 2010, 343, 223-229.
53. Durante, W. Carbon monoxide and bile pigments: surprising mediators of vascular function. Vasc Med., 2002, 7, 195-202. (Pubitemid 36104321)
54. Ferrara, N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev, 2004; 25, 581-611 (Pubitemid 39099316)
55. Shasby, D.M.; Ries, D.R.; Shasby, S.S.; Winter, M.C. Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin. Am. J. Physiol. Lung Cell Mol. Physiol., 2002, 282, L1330-8. (Pubitemid 34654590)
56. Pedram, A.; Razandi, M.; Levin, E.R. Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. J Biol Chem., 2002, 277, 44385-44398. (Pubitemid 36157874)
57. Lampugnani, M.G.; Zanetti, A.; Breviario, F.; Balconi, G.; Orsenigo, F.; Corada, M.; Spagnuolo, R.; Betson, M.; Braga, V.; Dejana, E. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol. Biol. Cell., 2002, 13, 1175-89. (Pubitemid 34309614)
58. Alghisi, G.C.; Ponsonnet, L.; Rüegg, C. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One., 2009, 4, e4449.
59. Lu, Q.; Rounds ,S.Focal adhesion kinase and endothelial cell apoptosis. Microvasc Res. 2011, May 19. Epub ahead of print
60. Zhang, Y.; Chen, M.; Venugopal, S.; Zhou, Y.; Xiang, W.; Li, Y.H.; Lin, Q.; Kini, R.M.; Chong, Y.S.; Ge, R. Isthmin exerts pro-survival and deathpromoting effect on endothelial cells through alphavbeta5 integrin depending on its physical state. Cell Death Dis., 2011, 5, e153.
61. Wang, Y.; Flores, L.; Lu, S.; Miao, H.; Li, Y.S.; Chien, S. Shear Stress Regulates the Flk-1/Cbl/PI3K/NF-κB Pathway Via Actin and Tyrosine Kinases. Cell Mol Bioeng., 2009, 2, 341-350.
62. Haendeler, J.; Tischler, V.; Hoffman, J.; Zeiher, A.M.; Dimmeler, S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett., 2004, 577, 427-433. (Pubitemid 39535325)
63. Potter, C.M.; Lundberg, M.H.; Harrington, L.S.; Warboys, C.M.; Warner, T.D.; Berson, R.E.; Moshkov, A.V.; Gorelik, J.; Weinberg, P.D.; Mitchell, J.A. Role of shear stress in endothelial cell morphology and expression of cyclooxygenase isoforms. Arterioscler Thromb Vasc Biol., 2011, 31, 384-91.
64. Li, A.; Cheng, G.; Zhu, G.H.; Tarnawski, A.S. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: Implications beyond GH release. Biochem Biophys Res Commun., 2007, 353, 238-43. (Pubitemid 46014561)
65. Ahluwalia, A.; Li, A.; Cheng, G.; Deng, X.; Tarnawski, A.S. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol,. 2009, 60, 29-34.
66. Schulz, F.; Antor, F.; Keaney, J.F. Oxidative stress, antioxidants and endothelium function. Curr Med Chem., 2004, 11, 1093-1104.
67. Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol., 2007, 27, 2524-31. (Pubitemid 350158901)
68. Taylor, C.T.; Moncada, S. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol., 2010, 30, 643-7.
69. Li, D-S.; Raybould, H.E.; Quintero, E.; Guth, P.H. Calcitonin gene-related peptide mediates the gastric hyperemic response to acid back-diffusion. Gastroenterology, 1992, 102, 1124-1128
70. Whittle, B.J. Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. Br J Pharmacol., 1993, 110, 3-17. (Pubitemid 23257750)
71. Zhang, Y.; Chen, H.; Yang, L. Toll-like receptor 4 participates in gastric mucosal protection through Cox-2 and PGE2. Dig Liver Dis, 2009, 42, 472-476.
72. Shin, H.S.; Xu, F.; Bagchi, A.; Herrup, E.; Prakash, A.; Valentine, C.; Kulkarni, H.; Wilhelmsen, K.; Warren, S.; Hellman, J. Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. J Immunol., 2011, 186, 1119-30.
73. Pawlik, M,; Ptak, A.; Pajdo, R.; Konturek, P.C.; Brzozowski, T.; Konturek, S.J. Sensory nerves and calcitonin gene related peptide in the effect of ischemic preconditioning on acute and chronic gastric lesions induced by ischemia-reperfusion. J Physiol Pharmacol. 2001, 52, 569-81. (Pubitemid 34164747)
74. Konturek, S.J.; Brzozowski, T.; Pajdo, R.; Konturek, P.C.; Kwiecień, S.; Sliwowski, Z.; Pawlik, M.; Ptak, A.; Drozdowicz, D.; Hahn, E.G. Gastric preconditioning induced by short ischemia: the role of prostaglandins, nitric oxide and adenosine. Med Sci Monit., 2001, 7, 610-21. (Pubitemid 32691736)
75. Pajdo, R.; Brzozowski, T.; Konturek, P.C.; Kwiecien, S.; Konturek, S.J.; Sliwowski, Z.; Pawlik, M.; Ptak, A.; Drozdowicz, D.; Hahn, E.G. Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves. Eur J Pharmacol., 2001, 427, 263-76. (Pubitemid 32913294)
76. Brzozowski, T.; Konturek, P.C.; Konturek, S.J.; Pajdo, R.; Kwiecien, S.; Pawlik, M.; Drozdowicz, D.; Sliwowski, Z.; Pawlik, W.W. Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves. Eur J Pharmacol. 2004, 499, 201-13. (Pubitemid 39201228)
77. Tarnawski, A.S.; Chai, J.; Jones, M.K. Esophageal and Gastrointestinal Microcirculation: Essential for Mucosal Protection, a Target for Injury, and a Critical Component of Injury and Ulcer Healing. In: Organ Microcirculation: A Gateway to Diagnostic and Therapeutic Interventions, Ishii H, et al ., Eds., Springer, Tokyo. 2005, pp. 49-61.
78. Trier, J.S.; Szabo, S.; Allan, C.H. Ethanol-induced damage to mucosal capillaries of rat stomach. Ultrastructural features and effects of prostaglandin F2B and cysteamine. Gastroenterology, 1987, 92, 13-22. (Pubitemid 17207656)
79. Tarnawski, A.; Hollander, D.; Stachura, J. Ultrastructural changes in the gastric mucosal microvessels after ethanol. Gastroenterol Clin Biol 1985, 9, 93-7. (Pubitemid 16179008)
80. Tarnawski, A.; Stachura, J.; Gergely, H.; Hollander, D. Microvascular endothelium: A major target for alcohol injury of the human gastric mucosa: Histochemical and ultrastructural study. J Clin Gastroenterol, 1988, 10, S53
81. Tarnawski, A.; Stachura, J.; Hollander, D.; Sarfeh, I.J.; Bogdal, J. Cellular aspects of alcohol-induced injury and prostaglandin protection of the human gastric mucosa. Focus on the mucosal microvessels. J Clin Gastroenterol., 1988, 10, S35-45.
82. Jones, M.K.; Padilla, O.R.; Zhu, E. Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury. J Physiol Pharmacol., 2010, 61, 253-64.
83. Halter, F.; Schmassmann, A.; Peskar, B.M.; Tarnawski, A.S. Cycloxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing: Controversial issues and perspectives. Gut, 2001, 49, 443-53. (Pubitemid 32802583)
84. Tarnawski, A.; Krause, W.J.; Ivey, K.J. Effect of glucagon on aspirininduced gastric mucosal damage in man. Gastroenterology. 1978, 74, 240-5. (Pubitemid 8275643)
85. Radi, Z.A.; Kehrli, M.E. Jr.; Ackermann, M.R. Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. J Vet Intern Med. 2001, 15, 516-29. (Pubitemid 33722418)
86. Kurose, I.; Wolf, R.; Miyasaka, M.; Anderson, D.C.; Granger, D.N. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. Am J Physiol., 1996, 270, G363-9.
87. Yoshida, N.; Yoshikawa, T.; Nakamura, Y.; Arai, M.; Matsuyama, K.; Iinuma, S.; Nishimura, S.; Kondo, M. Role of neutrophil-endothelial cell interactions in gastric mucosal injury induced by aspirin. J Clin Gastroenterol., 1995, 21, S73-7. (Pubitemid 26001721)
88. Husain, S.S.; Szabo, I.L.; Pai, R.; Soreghan, B.; Jones, M.K.; Tarnawski, A.S. MAPK (ERK2) kinase-a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth. Life Sci. 2001 Nov 9;69(25-26):3045-54. (Pubitemid 33044698)
89. Jones, M.K.; Wang, H.; Levin, E.; Itani, R.M.; Sarfeh, I.J.; Tarnawski, A.S. Inhibition of angiogenesis by NSAIDs. Insight into the mechanisms and implications for cancer growth and ulcer healing. Nature Med, 1999, 5,1418-23.
90. Tarnawski, A.S.; Jones, M.K. Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med., 2003, 81, 627-36. (Pubitemid 37357677)
91. Lanza, F.L.; Hubsher, J.A.; Walker, B.R. Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa. J Clin Pharmacol. 1981, 21, 157-61. (Pubitemid 11073350)
92. Robins, P.G. Ultrastructural observations on the pathogenesis of aspirininduced gastric erosions. Br J Exp Path 1980, 61, 497-504. (Pubitemid 11194414)
93. Tarnawski, A.; Stachura, J.; Gergely, H.; Hollander, D. Gastric microvascular endothelium: a major target for aspirin-induced injury and arachidonic acid protection. An ultrastructural analysis in the rat. Eur J Clin Invest. 1990, 20, 432-40 (Pubitemid 20259845)
94. Hollander, D.; Tarnawski, A.; Ivey, K.J.; DeZeery, A.; Zipser, R.D.; McKenzie, W.N. Jr.; McFarland, W.D. Arachidonic acid protection of rat gastric mucosa against ethanol injury. J Lab Clin Med., 1982, 100, 296-308. (Pubitemid 12054658)
95. Ohno, T.; Ohtsuki, H.; Okabe, S. Effects of 16,16-dimethyl prostaglandin E2 on ethanol-induced and aspirin-induced gastric damage in the rat. Scanning electron microscopic study. Gastroenterology. 1985, 88, 353-61. (Pubitemid 15224614)
96. Kitahora, T.; Guth, P.H. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 1987, 93, 810-17. (Pubitemid 17156007)
97. McGreevy, J.M.; Moody, F.G. Focal microcirculatory changes during the production of aspirin-induced gastric mucosal erosions. Surgery. 1981, 89, 337-41. (Pubitemid 11191558)
98. Chiou, S.K.; Moon, W.S.; Jones, M.K.; Tarnawski, A.S. Survivin expression in the stomach: implications for mucosal integrity and protection. Biochem Biophys Res Commun, 2003, 305, 374-9. (Pubitemid 36555479)
99. Chiou, S-K.; Tanigawa, T.; Akahoshi, T.; Abdelkarim, B.; Jones, M.K.; Tarnawski, A.S. Survivin -a novel target for indomethacin-induced gastric injury. Gastroenterology, 2005, 128, 63-73. (Pubitemid 40039959)
100. Chiou, S.K.; Jones, M.K.; Tarnawski, A.S. Survivin -an anti-apoptosis protein: its biological roles and implication for cancer and beyond. Med Sci Monit, 2003, 9, P125-9.
101. Chiou, S.K.; Mandayam, S. NSAIDs enhance proteasomic degradation of survivin, a mechanism of gastric epithelial cell injury and apoptosis. Biochem Pharmacol. 2007, 74, 1485-95. (Pubitemid 47575492)
102. Brand, S.J.; Morise, Z.; Tagerud, S.; Mazzola, L.; Granger, D.N.; Grisham, M.B. Role of the proteasome in rat indomethacin-induced gastropathy. Gastroenterology. 1999, 116, 865-73. (Pubitemid 29153534)
103. Jones, M.K.; Padilla, O.R.; Webb, N.A.; Norng, M. The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34(cdc2) cyclin-dependent kinase. J Cell Physiol., 2008, 215, 750-64. (Pubitemid 351632697)
104. Sarfeh, I.J.; Tabak, C.; Eugene, J.; Juler; G.L. Clinical significance of erosive gastritis in patients with alcoholic liver disease and upper gastrointestinal hemorrhage. Ann Surg 1981;194:149-151. (Pubitemid 11000044)
105. Auroux, J.; Lamarque, D.; Roudot-Thoraval, F.; Deforges, L.; Chaumette, M.T.; Richardet, J.P.; Delchier, J.C. Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci 2003;48:1118-1123. (Pubitemid 36667837)
106. Sarfeh, I.J.; Tarnawski, A.; Malki, A.; Mason, G.R.; Mach, T.; Ivey, K.J. Portal hypertension and gastric mucosal injury in rats: effects of alcohol. Gastroenterology 1983;84:987-993. (Pubitemid 13119912)
107. Sarfeh IJ; Tarnawski A. Portal hypertensive gastropathy. Gastroenterology 1987;93:1129-1131.
108. Kawanaka, H.; Jones, M.K.; Szabo, I.L.; Baatar, D.; Pai, R.; Tsugawa, K.; Sugimachi, K.; Sarfeh, I.J.; Tarnawski, A.S. Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-α; via the PI e-kinase-Akt signaling pathway. Hepatology 2002;35: 393-402. (Pubitemid 34106380)
109. Kawanaka, H.; Tomikawa, M.; Jones, M.K.; Pai, R.; Szabo, I.L.; Sugimachi, K.; Sarfeh, I.J.; Tarnawski, A.S. Portal hypertensive gastric mucosa has reduced activation of MAP kinase (ERK2) in response to alcohol injury: a key to impaired healing? FASEB J 2001;15:574-576.
110. Tomikawa, M.; Akiba, Y.; Kaunitz, J.D.; Kawanaka, H.; Sugimachi, K.; Sarfeh, I.J.; Tarnawski, A.S. New insight into impairment of mucosal defense in portal hypertensive gastric mucosa. J Gastrointest Surg 2000;4:458-463.
111. Tarnawski, A.; Sarfeh, I.J.; Stachura, J.; Hajduczek, A.; Bui, H.X.; Dabros, W.; Gergely, H. Microvascular abnormalities of the portal hypertensive gastric mucosa. Hepatology; 1988; 8; 1488-94. (Pubitemid 19021877)
112. Sarfeh, I.J.; Soliman, H.; Waxman, K.; Coccia, M.; Rypins, E.B.; Bui, H.X.; Tarnawski, A. Impaired oxygenation of gastric mucosa in portal hypertension: the basis for increased susceptibility to injury. Dig Dis Sci 1889;34:225-228.
113. Florkiewicz, R.Z.; Ahluwalia, A.; Sandor, Z.; Szabo, S.; Tarnawski, A.S. Gastric mucosal injury activates bFGF gene expression and triggers preferential translation of high molecular weight bFGF isoforms through CUG-initiated, non-canonical codons. Biochem Biophys Res Commun. 2011,409,494-499.
114. Logan, A.; Frautschy, S.A.; Gonzalez, A.M.; Baird, A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its highaffinity receptors (flg) following a localized cortical brain injury, J. Neurosci. 1992, 12, 3828-3837.
115. Gómez-Pinilla, F.; Cotman, C.W. Transient lesion-induced increase of basic fibroblast growth factor and its receptor in layer VIb (subplate cells) of the adult rat cerebral cortex, Neuroscience 1992, 49, 771-780.
116. Lindner, V.; Majack, R.A.; Reidy, M.A. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries, J. Clin. Invest. 1990, 85, 2004-2008. (Pubitemid 20192979)
117. Lindner, V.; Reidy, M.A. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study, Circ. Res. 1993, 73, 589-595. (Pubitemid 23238744)
118. R.Z. Florkiewicz, A. Baird, A.M. Gonzalez, Multiple forms of bFGF: differential nuclear and cell surface localization, Growth Factors 1991, 4, 265-275.
119. M. Arese, Y. Chen, R.Z. Florkiewicz, A. Gualandris, B. Shen, D.B. Rifkin, Nuclear activities of basic fibroblast growth factor: potentiation of lowserum growth mediated by natural or chimeric nuclear localization signals, Mol. Biol. Cell 10 (1999) 1429-1444. (Pubitemid 29230900)
120. K. Chlebova, V. Bryja, P. Dvorak, A. Kozubik, W.R. Wilcox, P. Krejci, High molecular weight FGF2: the biology of a nuclear growth factor, Cell. Mol. Life Sci. 66 (2009) 225-235.
121. E.Y. Lee, Y. Xia, W.S. Kim, M.H. Kim, T.H. Kim, K.J. Kim, B.S. Park, J.H. Sung, Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF, Wound Repair Regen. 17 (2009) 540-547.
122. M. Faris, B. Ensoli, N. Kokot, A.E. Nel, Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter, AIDS 12 (1998) 19-27.